Publications
5532 Results
- Journal / Conference
- Proc of the American Association for Cancer Research 38:521(#3494)
- Year
- 1997
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9009
Immunologic reconstitution following adjuvant 5FU and levamisole (LMS) correlates with disease free survival in stage III colon cancer: Report of Southwest Oncology Group (SWOG) protocol #9009.
- Journal / Conference
- Journal of Clinical Oncology 15(7):2494-2501
- Year
- 1997
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8312
Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor positive metastatic breast cancer: A Southwest Oncology Group phase III trial.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 16:128a(#450)
- Year
- 1997
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8814
Tamoxifen (T) versus cyclophosphamide, adriamycin and 5-FU plus either concurrent or sequential T in postmenopausal, receptor(+), node(+) breast cancer: a Southwest Oncology Group phase III intergroup trial (SWOG-8814, INT-0100).
- Journal / Conference
- Proc of the American Society of Clinical Oncology 16:446a(#1600)
- Year
- 1997
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9019
Concurrent cisplatin/etoposide plus radiotherapy (PE+RT) for pathologic stage (pathTN) IIIB non-small cell lung cancer(NSCLC): a Southwest Oncology Group (SWOG) phase II study (S9019).
- Journal / Conference
- Proc of the American Society of Clinical Oncology 16:13a(#46)
- Year
- 1997
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-9028
Alpha interferon plus alternate day prednisone (IFN/P) improves remission maintenance duration in multiple myeloma (MM) compared to IFN alone.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 16:355a(#1268)
- Year
- 1997
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-9132
A randomized phase II trial of 13-cis-retinoic acid (CRA) or all-trans-retinoic acid (ATRA) plus interferon alpha 2a (IFN) for metastatic or recurrent squamous/adenosquamous carcinoma of the uterine cervix: a Southwest Oncology Group study
- Journal / Conference
- Proc of the American Society of Clinical Oncology 16:491a(#1768)
- Year
- 1997
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-9223
Phase II trial of all-trans-retinoic acid (RA) plus alpha interferon (IFN) in stage IV melanoma (SWOG 9223).
- Journal / Conference
- Proc of the American Society of Clinical Oncology 16:224a(#787)
- Year
- 1997
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-9436 (NABTC-9403) (NCI T94-0184)
Effects of anticonvulsants (ACs) on the pharmacokinetics (PK) and metabolic profile of paclitaxel.
- Journal / Conference
- Cancer Genetics and Cytogenetics 99:45-53
- Year
- 1997
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-9136
Cytogenetic aberrations and DNA ploidy in soft tissue sarcoma: A Southwest Oncology Group study.
- Journal / Conference
- Proc Seventh International Workshop on Chromosomes in Solid Tumors :#21
- Year
- 1997
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9023